As part of an £18m programme in Regenerative Medicine, the Technology Strategy Board is to invest up to £1.5m in commercial research and development projects in the area of Regenerative Medicine: Value Systems and Business Models. Proposals should ideally be business led and business driven, and must clearly present the benefits to business.
Applications must be for collaborative R&D: there must be at least two consortium partners, one of which must be a business.

Challenge

To develop a better understanding of where and how value will be created in the regenerative medicine value chain, and to develop business models that will enable businesses to best capture that value.

Key dates

Competition opens 1st September 2009
Briefing (optional) 8th September 2009
Registration of intent to submit (compulsory) 8th October 2009 (midday)
Deadline for receipt of full applications 15th October 2009 (midday)
Decision and feedback to applicants 16th November 2009